Raloxifene osteoporosis drug molecule

Raloxifene osteoporosis drug molecule

A624/0432 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 48.5MB

Downloadable file size: 799.4KB

Price image Pricing

Please login to use the price calculator


Caption: Raloxifene osteoporosis drug, molecular model. This drug, marketed as Evista, is used to prevent osteoporosis in postmenopausal women. Oestrogen, a female sex hormone, increases the activity of osteoblasts, the cells that manufacture bone. When oestrogen levels fall after the menopause, women are at higher risk of osteoporosis, or reduced bone mineral density. Raloxifene mimics the effect of oestrogen in bone, stimulating bone production. However, as it blocks oestrogen receptors in other tissues, it causes fewer side effects than oestrogen itself. In this model, atoms are represented by coloured spheres; carbon is green, hydrogen is small and yellow, oxygen is blue, nitrogen is purple, and sulphur is large and yellow.

Release details: Model release not required. Property release not required.

Keywords: agonist, antagonist, artwork, ball and stick, ball-and-stick, biochemical, biochemistry, biological, chemical, chemistry, compound, compounds, computer artwork, drug, estraldiol, estrogen, evista, illustration, inhibitor, medical, medicine, modulator, molecular, molecular model, molecule, molecules, oestradiol, oestrogen, osteoporosis, osteoporotic, pharmaceutical, pharmaceutics, pharmacological, pharmacology, post-menopausal, postmenopausal, preventative, prevention, raloxifene, selective estrogen receptor, serm, sphere, spheres, structure, treatment

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.